KwaZulu Natal-based start-up Tri-Medi Canna has partnered with UK-listed pharmaceutical company Apollon Formularies to open a cannabis production plant in SA. Tri-Medi Canna was established to focus on medical cannabis, a booming industry that the company said is forecast to be worth up to $7.1bn (R113.7bn) by 2023 in Africa with SA potentially making up 70% of the current market.